UK markets closed

Virpax Pharmaceuticals, Inc. (VRPX)

NasdaqCM - NasdaqCM Delayed price. Currency in USD
Add to watchlist
3.6801-0.2299 (-5.88%)
At close: 04:00PM EDT
3.2600 -0.42 (-11.42%)
After hours: 04:28PM EDT
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Total revenue
0
0
0
0
0
Operating expenses
Research development
5,118
5,118
10,763
4,839
1,292
Selling general and administrative
11,822
11,822
11,082
7,186
2,904
Total operating expenses
16,940
16,940
21,845
12,026
4,196
Operating income or loss
-16,940
-16,940
-21,845
-12,025
-4,196
Interest expense
-
-
0
92.822
147.934
Total other income/expenses net
1,750
1,750
194.413
62.259
4
Income before tax
-15,190
-15,190
-21,651
-12,056
-4,340
Income tax expense
0
0
0
0
0
Income from continuing operations
-15,190
-15,190
-21,651
-12,056
-4,340
Net income
-15,190
-15,190
-21,651
-12,056
-4,340
Net income available to common shareholders
-15,190
-15,190
-21,651
-12,056
-4,340
Basic EPS
-1.17
-
-184.90
-18.10
-9.62
Diluted EPS
-1.17
-
-184.90
-18.10
-9.62
Basic average shares
11,714
-
117.102
667.727
450.879
Diluted average shares
11,714
-
117.102
667.727
450.879